Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus.
Avipoxviruses have recently been studied as potential vectors for the delivery of heterologous vaccine antigen. Because these viruses abortively infect mammalian cells yet still effectively present encoded foreign genes to the host immune system, they offer a safer but effective alternative to other live virus vectors. We have examined the effect of coexpressing the cytokine interleukin-6 or gamma interferon on immune responses to a recombinant fowlpox virus expressing influenza virus hemagglutinin. The encoded cytokine was expressed for prolonged periods in infected cell culture with little cytopathic effect due to the abortive nature of the infection. In mice, vector-expressed cytokine dramatically altered immune responses induced by the coexpressed hemagglutinin antigen. Expression of interleukin-6 augmented both primary systemic and mucosal antibody responses and primed for enhanced recall responses. In contrast, expression of gamma interferon markedly inhibited antibody responses without affecting the generation of cell-mediated immunity. The safety of these constructs was demonstrated in mice with severe combined immunodeficiency, and no side effects due to cytokine expression were observed. In summary, fowlpox virus vectors encoding cytokines represent a safe and effective vaccine strategy which may be used to selectively manipulate the immune response.
Viral Engineering and Cytokine Research Group, John Curtin School of Medical Research, Australian National University, Canberra.
K H
KH
Leong
A J
AJ
Ramsay
D B
DB
Boyle
I A
IA
Ramshaw
D000818:Animals; D000917:Antibody Formation; D001483:Base Sequence; D002478:Cells, Cultured; D002642:Chick Embryo; D017931:DNA Primers; D005587:Fowlpox virus / Q000276:immunology*; D015870:Gene Expression; D005822:Genetic Vectors; D007111:Immunity, Cellular; D007114:Immunization / Q000379:methods; D007371:Interferon-gamma / Q000008:administration & dosage / Q000096:biosynthesis* / Q000276:immunology; D015850:Interleukin-6 / Q000008:administration & dosage / Q000096:biosynthesis* / Q000276:immunology; D007739:L Cells; D051379:Mice; D008808:Mice, Inbred CBA; D016513:Mice, SCID; D008969:Molecular Sequence Data; D016133:Polymerase Chain Reaction; D011995:Recombination, Genetic; D012867:Skin; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D017931:DNA Primers; D015850:Interleukin-6; D007371:Interferon-gamma